Maria Younes, Ghady Loubnane, Christopher Sleiman, Sandra Rizk
{"title":"Tocotrienol isoforms: The molecular mechanisms underlying their effects in cancer therapy and their implementation in clinical trials","authors":"Maria Younes, Ghady Loubnane, Christopher Sleiman, Sandra Rizk","doi":"10.1016/j.joim.2024.01.002","DOIUrl":"10.1016/j.joim.2024.01.002","url":null,"abstract":"<div><p><span>Tocotrienols<span> are found in a variety of natural sources, like rice bran, annatto seeds and palm oil, and have been shown to have several health-promoting properties, particularly against chronic diseases such as cancer. The incidence of cancer is rapidly increasing around the world, not only a result of continued aging and population growth, but also due to the adoption of aspects of the Western lifestyle, such as high-fat diets and low-physical activity. The literature provides strong evidence that tocotrienols are able to inhibit the growth of various cancers, including breast, lung, ovarian, prostate, liver, brain, colon, myeloma<span><span><span> and pancreatic cancers. These findings, along with the reported safety profile of tocotrienols in healthy human volunteers, encourage further research into these compounds’ potential use in cancer prevention and treatment. The current review provided detailed information about the molecular mechanisms of action of different tocotrienol isoforms in various cancer models and evaluated the potential therapeutic effects of different </span>vitamin E<span><span> analogues on important cancer hallmarks, such as cellular proliferation, </span>apoptosis<span>, angiogenesis<span> and metastasis. MEDLINE/PubMed and Scopus databases were used to identify recently published articles that investigated the anticancer effects of </span></span></span></span>vitamin E derivatives in various types of cancer in vitro and in vivo along with clinical evidence of adjuvant chemopreventive benefits. Following an overview of pre-clinical studies, we describe several completed and ongoing </span></span></span>clinical trials<span> that are paving the way for the successful implementation of tocotrienols in cancer chemotherapy.</span></p></div>","PeriodicalId":48599,"journal":{"name":"Journal of Integrative Medicine-Jim","volume":"22 1","pages":"Pages 1-11"},"PeriodicalIF":4.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139499404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yue-ying Ma , Zhou Hao , Zi-yi Chen , Yan-xi Shen , Hui-rong Liu , Huan-gan Wu , Chun-hui Bao
{"title":"Acupuncture and moxibustion for irritable bowel syndrome: An umbrella systematic review","authors":"Yue-ying Ma , Zhou Hao , Zi-yi Chen , Yan-xi Shen , Hui-rong Liu , Huan-gan Wu , Chun-hui Bao","doi":"10.1016/j.joim.2023.12.001","DOIUrl":"10.1016/j.joim.2023.12.001","url":null,"abstract":"<div><h3>Background</h3><p>Irritable bowel syndrome (IBS) is a functional bowel disease characterized by abdominal pain or discomfort associated with altered bowel habits. Several clinical studies have demonstrated the effectiveness of acupuncture and moxibustion for IBS. Many systematic reviews of acupuncture and moxibustion for IBS have been published in recent years, but their results are not entirely consistent.</p></div><div><h3>Objective</h3><p>To evaluate the methodological, reporting, and evidence quality of systematic reviews of acupuncture and moxibustion for IBS.</p></div><div><h3>Search strategy</h3><p>Systematic reviews of acupuncture and moxibustion for IBS published before February 20, 2023 were searched in eight databases: PubMed, Embase, Cochrane Library, Web of Science, China National Knowledge Infrastructure, Wanfang Data, VIP Database for Chinese Technical Periodicals, and China Biology Medicine. The keywords used for literature search were acupuncture, moxibustion, systematic review, meta-analysis, and irritable bowel syndrome.</p></div><div><h3>Inclusion criteria</h3><p>Systematic reviews and meta-analyses of randomized controlled trials of acupuncture and moxibustion for IBS were included.</p></div><div><h3>Data extraction and analysis</h3><p>Relevant information was independently extracted by two investigators. The A MeaSurement Tool to Assess systematic Reviews 2 (AMSTAR 2), Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA 2020), and Grading of Recommendations Assessment, Development and Evaluation (GRADE) were used to evaluate the methodological quality, reporting quality and evidence quality, respectively.</p></div><div><h3>Results</h3><p>A total of 342 studies were retrieved and 15 systematic reviews were included. The results of AMSTAR 2 showed low methodological quality in 2 studies and very low methodological quality in the remaining 13 studies, with main issues being failure to register a protocol, incomplete search strategy, not providing a list of excluded studies, incomplete consideration of the risk of bias in the included studies, and a failure to assess the publication bias. The results of PRISMA 2020 showed seriously deficient reporting quality of 2 studies, somewhat deficient reporting quality of 12 studies, and relatively complete reporting quality of 1 study, with the main problems being lack of a complete search strategy, non-availability of a list of excluded studies with justification for their exclusion, not conducting heterogeneity and sensitivity analyses, not evaluating the credibility of the evidence, and not registering the protocol. The results of GRADE showed that the quality of the evidence is low or very low.</p></div><div><h3>Conclusion</h3><p>Most included systematic reviews interpreted findings to suggest that acupuncture and moxibustion have benefits for IBS. However, there is a need to improve the methodological, reporting and evidence quality of the systematic ","PeriodicalId":48599,"journal":{"name":"Journal of Integrative Medicine-Jim","volume":"22 1","pages":"Pages 22-31"},"PeriodicalIF":4.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2095496423000985/pdfft?md5=9c757eeab4d5876b083f9640ef681246&pid=1-s2.0-S2095496423000985-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139028503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Matthias Huemer , Sandro Graca , Sarah Bitsche , Guenter Hofmann , Mike Armour , Martin Pichler
{"title":"Mapping the clinical practice of traditional, complementary and integrative medicine in oncology in Western countries: A multinational cross-sectional survey","authors":"Matthias Huemer , Sandro Graca , Sarah Bitsche , Guenter Hofmann , Mike Armour , Martin Pichler","doi":"10.1016/j.joim.2023.12.002","DOIUrl":"10.1016/j.joim.2023.12.002","url":null,"abstract":"<div><h3>Background</h3><p>Many cancer patients seek adjunctive therapies to biomedical cancer treatments at some point of their disease trajectory. While acupuncture is increasingly recommended by leading oncological associations, limited evidence exists concerning the evidence-informed practice and adherence to current guidelines of traditional complementary and integrative medicine (TCIM) practitioners treating cancer patients.</p></div><div><h3>Methods</h3><p>An international online-survey assessed the demographical data, clinical practice, and sources of information used by TCIM practitioners in Austria, Germany, United States of America, Australia, and New Zealand.</p></div><div><h3>Results</h3><p>In total, 404 respondents completed the survey, of which 254 (62.9%) treated cancer patients. Most practitioners were acupuncturists and herbalists (57.1%), had (16.8 ± 9.9) years of clinical experience and see a median of 2 (1, 4) cancer patients per week. Breast cancer (61.8%) is the most common cancer type seen in TCIM clinics. Adjunctive TCIM treatments are frequently concurrent with the patient’s cancer specific treatment (39.9%), which is also reflected by the main goal of a TCIM treatment to alleviate side effects (52.4%). However, only 28.0% of the respondents are in contact with the treating oncologist. According to the respondents, pain is most effectively treated using acupuncture, while herbal medicine is best for cancer-related fatigue. TCIM practitioners mostly use certified courses (33.1%) or online databases (28.3%) but often believe that experts are more reliable to inform their practice (37.0%) than research publications (32.7%).</p></div><div><h3>Conclusion</h3><p>Acupuncturists and herbalists commonly treat cancer patients. Most practitioners use TCIM as an adjunct to biomedicine as supportive care and use it largely in accordance with current oncological guidelines.</p></div><div><h3>Please cite this article as</h3><p>Huemer M, Graca S, Bitsche S, Hofmann G, Armour M, Pichler M. Mapping the clinical practice of traditional, complementary and integrative medicine in oncology in Western countries: A multinational cross-sectional survey. <em>J Integr Med</em>. 2024; 22(1): 64–71.</p></div>","PeriodicalId":48599,"journal":{"name":"Journal of Integrative Medicine-Jim","volume":"22 1","pages":"Pages 64-71"},"PeriodicalIF":4.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2095496423000997/pdfft?md5=f637883b5829283bfea8ef2a3c578818&pid=1-s2.0-S2095496423000997-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139052180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jun-yan He , Xiao-yu Tu , Zi-fei Yin , Hui Mu , Ming-jun Luo , Xing-yu Chen , Wei-bin Cai , Xue Zhao , Can Peng , Fan-fu Fang , Can Lü , Bai Li
{"title":"Short-term effects of cupping and scraping therapy for chronic nonspecific low-back pain: A prospective, multicenter randomized trial","authors":"Jun-yan He , Xiao-yu Tu , Zi-fei Yin , Hui Mu , Ming-jun Luo , Xing-yu Chen , Wei-bin Cai , Xue Zhao , Can Peng , Fan-fu Fang , Can Lü , Bai Li","doi":"10.1016/j.joim.2024.01.004","DOIUrl":"10.1016/j.joim.2024.01.004","url":null,"abstract":"<div><h3>Background</h3><p>As one of the most common musculoskeletal ailments, chronic nonspecific low-back pain (CNLBP) causes persistent disability and substantial medical expenses. Epidemiological evidence shows that the incidence rate of CNLBP in young and middle-aged people who are demanded rapidly recovery and social contribution is rising. Recent guidelines indicate a reduced role for medicines in the management of CNLBP.</p></div><div><h3>Objective</h3><p>The present study investigates the short-term effects of cupping and scraping therapy<span> using a medicated balm, compared to nonsteroidal anti-inflammatory drug (NSAID) with a capsaicin plaster, in the treatment of CNLBP.</span></p></div><div><h3>Design, setting, participants and interventions</h3><p>We designed a prospective multicenter randomized clinical trial<span> enrolling patients from January 1, 2022 to December 31, 2022. A total of 156 patients with CNLBP were randomized into two parallel groups. Diclofenac sodium-sustained release tablets were administered orally to participants in the control group for one week while a capsaicin plaster was applied externally. Patients in the test group were treated with cupping and scraping using a medical device and medicated balm.</span></p></div><div><h3>Main outcome measures</h3><p><span>Primary outcome was pain recorded using the visual analogue scale<span> (VAS). Two secondary outcomes were recorded using the Japanese Orthopedic Association low-back pain scale (JOA) and the </span></span>traditional Chinese medicine (TCM) syndrome integral scale (TCMS) as assessment tools.</p></div><div><h3>Results</h3><p>Between baseline and postintervention, all changes in outcome metric scales were statistically significant (<em>P</em><span> < 0.001). Compared to the control group, patients in the test group had a significantly greater treatment effect in all outcome variables, as indicated by lower VAS and TCMS scores and higher JOA scores, after the one-week intervention period (</span><em>P</em><span> < 0.001). Further, according to the findings of multivariate linear regression analysis<span>, the participants’ pain (VAS score) was related to their marital status, age, smoking habits and body mass index. No adverse reactions were reported for any participants in this trial.</span></span></p></div><div><h3>Conclusion</h3><p>The effectiveness of TCM combined with the new physiotherapy tool is superior to that of NSAID combined with topical plasters, regarding to pain intensity, TCM symptoms<span> and quality of life. The TCM plus physiotherapy also showed more stable and long-lasting therapeutic effects.</span></p></div><div><h3>Trial registration</h3><p>This study was registered at Chinese Clinical Trial Registry (ChiCTR2200055655).</p><p>Please cite this article as: He JY, Tu XY, Yin ZF, Mu H, Luo MJ, Chen XY, Cai WB, Zhao X, Peng C, Fang FF, Lü C, Li B. Short-term effects of cupping and scraping therapy for chronic nonspecific low-back ","PeriodicalId":48599,"journal":{"name":"Journal of Integrative Medicine-Jim","volume":"22 1","pages":"Pages 39-45"},"PeriodicalIF":4.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139554475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Identifying behavioral determinants and stage of readiness for performing knee massage among individuals with knee osteoarthritis: An observational study","authors":"Donya Nemati , Niki Munk , Navin Kaushal","doi":"10.1016/j.joim.2024.01.006","DOIUrl":"10.1016/j.joim.2024.01.006","url":null,"abstract":"<div><h3>Objective</h3><p><span>Patients who experience knee osteoarthritis or chronic knee pain can alleviate their </span>symptoms by performing self-knee massage. Understanding the readiness and types of determinants needed to facilitate self-knee massage is needed to design effective, theory-informed interventions. The primary objective of this study was to apply the transtheoretical model of behavior change to identify how factors, which include the type of knee condition and pain level, predict an individual’s readiness to adopt self-knee massage. The secondary objective employed the capability, opportunity and motivation-behavior (COM-B) model to identify relevant determinants that are predictive of an individual’s readiness to undertake self-knee massage.</p></div><div><h3>Methods</h3><p>An observational study design was used to recruit individuals with knee osteoarthritis (<em>n</em> = 270) and chronic knee pain (<em>n</em><span> = 130). Participants completed an online survey that assessed the transtheoretical model of behavior change stages, COM-B determinants (capability, opportunity and motivation), along with self-administered massage behavior. Multivariate analysis of covariance and structural equation modeling were used to test the primary and secondary objective, respectively.</span></p></div><div><h3>Results</h3><p>Participants who had knee osteoarthritis scored higher on the action stage compared to those with chronic pain (<em>P</em> = 0.003), and those who experienced greater level of pain scored higher in the contemplation (<em>P</em> < 0.001) and action phases (<em>P</em> < 0.001) of performing knee massage compared to those with milder pain. The COM-B structural equation model revealed self-administered knee massage to be predicted by capability (β = 0.31, <em>P</em> = 0.004) and motivation (β = 0.29, <em>P</em> < 0.001), but not opportunity (β = –0.10, <em>P</em> = 0.39). Pain level predicted motivation (β = 0.27, <em>P</em> < 0.001), but not capability (β = 0.09, <em>P</em> = 0.07) or opportunity (β = 0.01, <em>P</em> = 0.83). Tests for mediating effects found that determinants of COM-B (motivation and capability) mediate between pain level and self-administered massage behavior (β = 0.10, <em>P</em> = 0.002).</p></div><div><h3>Conclusion</h3><p>Clinicians and researchers can expect that patients diagnosed with knee osteoarthritis or who have chronic knee pain are ready (action stage) or are considering the behavior (contemplation stage) of self-knee massage. Individuals who report having knee osteoarthritis or chronic knee pain should be coached to develop the skills to perform self-knee massage and helped to develop the motivation to carry out the therapy.</p><p>Please cite this article as: Nemati D, Munk N, Kaushal N. Identifying behavioral determinants and stage of readiness for performing knee massage among individuals with knee osteoarthritis: an observational study. <em>J Integr Med</em>. 2024; 22(1): ","PeriodicalId":48599,"journal":{"name":"Journal of Integrative Medicine-Jim","volume":"22 1","pages":"Pages 54-63"},"PeriodicalIF":4.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139554554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rosemary Arnold , Jenifer Murphy-Smith , Chee H. Ng , David Mischoulon , Gerard J. Byrne , Chad A. Bousman , Con Stough , Michael Berk , Jerome Sarris
{"title":"Predictors of the placebo response in a nutraceutical randomized controlled trial for depression","authors":"Rosemary Arnold , Jenifer Murphy-Smith , Chee H. Ng , David Mischoulon , Gerard J. Byrne , Chad A. Bousman , Con Stough , Michael Berk , Jerome Sarris","doi":"10.1016/j.joim.2024.01.007","DOIUrl":"10.1016/j.joim.2024.01.007","url":null,"abstract":"<div><h3>Objective</h3><p>The placebo response in depression studies is the change in symptoms amongst those who receive an inactive treatment. Many well-designed randomized controlled trials (RCTs) of depression have a high proportion of placebo responders, with little understanding as to why. The present study assesses characteristics associated with the placebo response in a nutraceutical trial with a large proportion of placebo responders.</p></div><div><h3>Methods</h3><p>This is a secondary analysis of a nutraceutical depression RCT which identified no overall treatment benefit relative to placebo (<em>n</em> = 69 in placebo group). We investigated participant characteristics such as socio-demographics, clinical features, and recruitment methods, and their association with the placebo response. Monoaminergic genetic polymorphisms were also assessed. Placebo response was measured based on change in Montgomery-Asberg Depression Rating Scale score. The association of these hypothesis-driven variables of interest and the placebo response was examined using linear mixed effects models.</p></div><div><h3>Results</h3><p>Greater levels of education, particularly pursuing post-high school education, better self-reported general health, marriage/de facto, greater improvement in the first trial week, and more failed antidepressant therapies in the current depressive episode were associated with greater placebo response. An increased placebo response was not found in those recruited via social media nor in those with concomitant antidepressant therapy. Single nucleotide polymorphisms from the tryptophan hydroxylase 1 (<em>TPH1</em>) gene (<em>A779C</em> and <em>A218C</em>) were weakly associated with greater placebo response, although the evidence was attenuated after accounting for multiple comparisons.</p></div><div><h3>Conclusion</h3><p>This is, to our knowledge, the first study within nutraceutical research for depression to assess the association between participant characteristics and variation in the placebo response. Several variables appeared to predict the placebo response. Such findings may encourage future trial designs which could dampen placebo response, improve assay sensitivity, and allow for treatment effects to be potentially more detectable.</p><p>Please cite this article as: Arnold R, Murphy-Smith J, Ng CH, Mischoulon D, Byrne GJ, Bousman CA, Stough C, Berk M, Sarris J. Predictors of the placebo response in a nutraceutical randomized controlled trial for depression. <em>J Integr Med</em>. 2024; 22(1): 46–53.</p></div>","PeriodicalId":48599,"journal":{"name":"Journal of Integrative Medicine-Jim","volume":"22 1","pages":"Pages 46-53"},"PeriodicalIF":4.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2095496424000074/pdfft?md5=c9a4760d210596822c3c4e56242bde72&pid=1-s2.0-S2095496424000074-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139554476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Li-ying Liu , Yang Su , Rong-rong Wang , Yuan-yuan Lai , Lei Huang , Yi-ting Li , Xin-yue Tao , Meng-hua Su , Xiao-yan Zheng , Shi-chen Huang , Yong-na Wu , Si-yi Yu , Fan-rong Liang , Jie Yang
{"title":"Transcutaneous electrical acupoint stimulation benefits postoperative pain relief of oocyte retrieval: A randomized controlled trial","authors":"Li-ying Liu , Yang Su , Rong-rong Wang , Yuan-yuan Lai , Lei Huang , Yi-ting Li , Xin-yue Tao , Meng-hua Su , Xiao-yan Zheng , Shi-chen Huang , Yong-na Wu , Si-yi Yu , Fan-rong Liang , Jie Yang","doi":"10.1016/j.joim.2024.01.005","DOIUrl":"10.1016/j.joim.2024.01.005","url":null,"abstract":"<div><h3>Background</h3><p>Transvaginal oocyte retrieval is frequently followed by adverse events related to anesthesia and the procedure. Some research showed that transcutaneous electrical acupoint stimulation (TEAS) can relieve intraoperative pain and postoperative nausea.</p></div><div><h3>Objective</h3><p>This study examined whether TEAS can alleviate pain and relieve adverse symptoms after oocyte retrieval.</p></div><div><h3>Design, setting, participants and interventions</h3><p>Altogether 128 patients were randomly divided into the TEAS group and the mock TEAS group. The two groups received a 30-minute-long TEAS or mock TEAS treatment that began 30 min after oocyte retrieval.</p></div><div><h3>Main outcome measures</h3><p>The primary outcome was the visual analog scale (VAS) pain score. Secondary outcomes were pressure pain threshold, McGill score, pain rating index (PRI), present pain intensity (PPI), VAS stress score, VAS anxiety score, and postoperative adverse symptoms.</p></div><div><h3>Results</h3><p>The baseline characteristics of the two groups were comparable (<em>P</em> > 0.05). The VAS pain scores of the TEAS group were lower than those of the mock TEAS group at 60 and 90 min after oocyte retrieval (<em>P</em> < 0.05). The McGill score, PRI and PPI in the TEAS group were significantly lower than those in the control group at 60 min after oocyte retrieval (<em>P</em> < 0.05). However, the two groups had equivalent beneficial effects regarding the negative emotions, such as nervousness and anxiety (<em>P</em> > 0.05). The TEAS group was superior to the mock TEAS group for relieving postoperative adverse symptoms (<em>P</em> < 0.05).</p></div><div><h3>Conclusion</h3><p>TEAS treatment can relieve postoperative pain and postoperative adverse symptoms for patients undergoing oocyte retrieval.</p><p>Please cite this article as: Liu LY, Su Y, Wang RR, Lai YY, Huang L, Li YT, Tao XY, Su MH, Zheng XY, Huang SC, Wu YN, Yu SY, Liang FR, Yang J. Transcutaneous electrical acupoint stimulation benefits postoperative pain relief of oocyte retrieval: A randomized controlled trial. <em>J Integr Med</em>. 2024; 22(1): 32–38.</p></div>","PeriodicalId":48599,"journal":{"name":"Journal of Integrative Medicine-Jim","volume":"22 1","pages":"Pages 32-38"},"PeriodicalIF":4.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139554440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lu-lu Han , Xin Zhang , Hui Zhang , Ting Li , Yi-chen Zhao , Ming-hui Tian , Feng-lei Sun , Bo Feng
{"title":"Alisol B 23-acetate promotes white adipose tissue browning to mitigate high-fat diet-induced obesity by regulating mTOR-SREBP1 signaling","authors":"Lu-lu Han , Xin Zhang , Hui Zhang , Ting Li , Yi-chen Zhao , Ming-hui Tian , Feng-lei Sun , Bo Feng","doi":"10.1016/j.joim.2024.01.003","DOIUrl":"10.1016/j.joim.2024.01.003","url":null,"abstract":"<div><h3>Objective</h3><p>Obesity is a global health concern with management strategies encompassing bariatric surgery and anti-obesity drugs; however, concerns regarding complexities and side effects persist, driving research for more effective, low-risk strategies. The promotion of white adipose tissue (WAT) browning has emerged as a promising approach. Moreover, alisol B 23-acetate (AB23A) has demonstrated efficacy in addressing metabolic disorders, suggesting its potential as a therapeutic agent in obesity management. Therefore, in this study, we aimed to investigate the therapeutic potential of AB23A for mitigating obesity by regulating metabolic phenotypes and lipid distribution in mice fed a high-fat diet (HFD).</p></div><div><h3>Methods</h3><p>An obesity mouse model was established by administration of an HFD. Glucose and insulin metabolism were assessed via glucose and insulin tolerance tests. Adipocyte size was determined using hematoxylin and eosin staining. The expression of browning markers in WAT was evaluated using Western blotting and quantitative real-time polymerase chain reaction. Metabolic cage monitoring involved the assessment of various parameters, including food and water intake, energy metabolism, respiratory exchange rates, and physical activity. Moreover, oil red O staining was used to evaluate intracellular lipid accumulation. A bioinformatic analysis tool for identifying the molecular mechanisms of traditional Chinese medicine was used to examine AB23A targets and associated signaling pathways.</p></div><div><h3>Results</h3><p>AB23A administration significantly reduced the weight of obese mice, decreased the mass of inguinal WAT, epididymal WAT, and perirenal adipose tissue, improved glucose and insulin metabolism, and reduced adipocyte size. Moreover, treatment with AB23A promoted the expression of browning markers in WAT, enhanced overall energy metabolism in mice, and had no discernible effect on food intake, water consumption, or physical activity. In 3T3-L1 cells, AB23A inhibited lipid accumulation, and both AB23A and rapamycin inhibited the mammalian target of rapamycin-sterol regulatory element-binding protein-1 (mTOR-SREBP1) signaling pathway. Furthermore, 3-isobutyl-1-methylxanthine, dexamethasone and insulin, at concentrations of 0.25 mmol/L, 0.25 μmol/L and 1 μg/mL, respectively, induced activation of the mTOR-SREBP1 signaling pathway, which was further strengthened by an mTOR activator MHY1485. Notably, MHY1485 reversed the beneficial effects of AB23A in 3T3-L1 cells.</p></div><div><h3>Conclusion</h3><p>AB23A promoted WAT browning by inhibiting the mTOR-SREBP1 signaling pathway, offering a potential strategy to prevent obesity.</p><p>Please cite this article as: Han LL, Zhang X, Zhang H, Li T, Zhao YC, Tian MH, Sun FL, Feng B. Alisol B 23-acetate promotes white adipose tissue browning to mitigate high-fat diet-induced obesity by regulating mTOR-SREBP1 signaling. <em>J Integr Med</em>. 2024; 22(1): 83–92.</","PeriodicalId":48599,"journal":{"name":"Journal of Integrative Medicine-Jim","volume":"22 1","pages":"Pages 83-92"},"PeriodicalIF":4.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2095496424000037/pdfft?md5=aa5eacc46ad058398ada8236b7b97dab&pid=1-s2.0-S2095496424000037-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139554766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jing-shun Meng , Yun He , Heng-bin Yang , Li-ping Zhou , Si-yuan Wang , Xi-lin Feng , Omar Yahya Al-shargi , Xiao-min Yu , Li-qing Zhu , Chang-quan Ling
{"title":"Melittin analog p5RHH enhances recombinant adeno-associated virus transduction efficiency","authors":"Jing-shun Meng , Yun He , Heng-bin Yang , Li-ping Zhou , Si-yuan Wang , Xi-lin Feng , Omar Yahya Al-shargi , Xiao-min Yu , Li-qing Zhu , Chang-quan Ling","doi":"10.1016/j.joim.2024.01.001","DOIUrl":"10.1016/j.joim.2024.01.001","url":null,"abstract":"<div><h3>Objective</h3><p><span><span>Melittin<span> and its derivative have been developed to support effective gene delivery systems. Their ability to facilitate endosomal release enhances the delivery of nanoparticle-based gene therapy. Nevertheless, its potential application in the context of viral vectors has not received much attention. Therefore, we would like to optimize the </span></span>rAAV vector<span> by Melittin analog to improve the transduction efficiency of rAAV in liver </span></span>cancer cells and explore the mechanism of Melittin analog on rAAV.</p></div><div><h3>Methods</h3><p><span>Various melittin-derived peptides were inserted into loop VIII of the capsid protein in recombinant adeno-associated virus vectors. These vectors carrying either </span><span><em>gfp</em></span> or <em>fluc</em><span><span> genes were subjected to quantitative polymerase chain reaction assays and transduction assays in human embryonic kidney 293 (HEK293T) cells to investigate the efficiency of vector production and gene delivery. In addition, the ability of a specific p5RHH-rAAV vector to deliver genes was examined through in vitro transduction of different cultured cells and in vivo </span>tail vein<span> administration to C57BL/6 mice. Finally, the intricate details of the vector-mediated transduction mechanisms were explored by using pharmacological inhibitors of every stage of the rAAV2 intracellular life cycle.</span></span></p></div><div><h3>Results</h3><p>A total of 76 melittin-related peptides were identified from existing literature. Among them, CMA-3, p5RHH and aAR3 were found to significantly inhibit transduction of rAAV2 vector crude lysate. The p5RHH-rAAV2 vectors efficiently transduced not only rAAV-potent cell lines but also cell lines previously considered resistant to rAAV. Mechanistically, bafilomycin A1<span>, a vacuolar endosome acidification inhibitor, completely inhibited the transgene expression mediated by the p5RHH-rAAV2 vectors. Most importantly, p5RHH-rAAV8 vectors also increased hepatic transduction in vivo in C57BL/6 mice.</span></p></div><div><h3>Conclusion</h3><p>The incorporation of melittin analogs into the rAAV capsids results in a significant improvement in rAAV-mediated transgene expression. While further modifications remain an area of interest, our studies have substantially broadened the pharmacological prospects of melittin in the context of viral vector-mediated gene delivery.</p><p>Please cite this article as: Meng J, He Y, Yang H, Zhou L, Wang S, Feng X, Al-shargi OY, Yu X, Zhu L, Ling, C. Melittin analog p5RHH enhances recombinant adeno-associated virus transduction efficiency. <em>J Integr Med.</em> 2024; 22(1): 72–82.</p></div>","PeriodicalId":48599,"journal":{"name":"Journal of Integrative Medicine-Jim","volume":"22 1","pages":"Pages 72-82"},"PeriodicalIF":4.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139499619","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Promoting whole person health: Exploring the role of traditional Chinese medicine in Polish healthcare","authors":"Monika Rybicka , Jing Zhao , Karolina Piotrowicz , Sara Ptasnik , Kamila Mitka , Magdalena Kocot-Kępska , Ka-Kit Hui","doi":"10.1016/j.joim.2023.10.001","DOIUrl":"10.1016/j.joim.2023.10.001","url":null,"abstract":"<div><p>Poland has a unique history of traditional Chinese medicine (TCM) dating back to the 17th century when Polish missionary Michael (Michał) Boym was a pioneer in the field. In the 20th century, his successor, Professor Zbigniew Garnuszewski, reintroduced acupuncture to medical practice in Poland. However, other methods of TCM and its holistic approach to patient care have not found their place in modern medicine in Poland. At present, the legal status of TCM in Poland remains unregulated, with TCM included in the broad spectrum of complementary and alternative medicine (CAM) practices. Few reports are available on the use of TCM methods among the Polish population. Integrative medicine combines conventional medicine with evidence-based CAM interventions and considers all aspects of a patient’s health, including physical, emotional, mental, social, and environmental factors. An integrative healthcare model that incorporates TCM modalities and lifestyle recommendations as well as a whole person approach may provide a more sustainable solution for the constantly underfinanced Polish healthcare system, which faces challenges of multimorbidity in an aging society and limited access to care. The coronavirus disease 2019 pandemic, war in Ukraine, and ongoing climate crisis have underscored the need to strengthen the resilience of the Polish healthcare system and search for new solutions. A model of care that blends the best of biomedicine and TCM healing approaches may be a better option for both patients and the healthcare system in Poland.</p><p>Please cite this article as: Rybicka M, Zhao J, Piotrowicz K, Ptasnik S, Mitka K, Kocot-Kępska M, Hui KK. Promoting whole person health: Exploring the role of traditional Chinese medicine in Polish healthcare. <em>J Integr Med</em>. 2023; 21(6): 509–517.</p></div>","PeriodicalId":48599,"journal":{"name":"Journal of Integrative Medicine-Jim","volume":"21 6","pages":"Pages 509-517"},"PeriodicalIF":4.8,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S209549642300078X/pdfft?md5=086c053321e44bbff6189eac9f60a87a&pid=1-s2.0-S209549642300078X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71482501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}